About Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals uses AI and automation to accelerate drug discovery — clinical-stage with major pharma partnerships. No dividend, high volatility, meme-stock tendencies. Premiums look tempting but binary trial outcomes and persistent cash burn create serious CSP assignment risk.
Biotechnology